KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Cash from Operations (2016 - 2025)

Teladoc Health (TDOC) has disclosed Cash from Operations for 12 consecutive years, with 87742000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 2.14% to 87742000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 294357000.0 through Dec 2025, changed 0.23% year-over-year, with the annual reading at 294357000.0 for FY2025, 0.23% changed from the prior year.
  • Cash from Operations hit 87742000.0 in Q4 2025 for Teladoc Health, down from 99264000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 130082000.0 in Q4 2023 to a low of 31747000.0 in Q1 2022.
  • Historically, Cash from Operations has averaged 66067000.0 across 5 years, with a median of 84555000.0 in 2021.
  • Biggest YoY gain for Cash from Operations was 172.4% in 2021; the steepest drop was 185.22% in 2021.
  • Year by year, Cash from Operations stood at 83208000.0 in 2021, then dropped by 21.22% to 65549000.0 in 2022, then soared by 98.45% to 130082000.0 in 2023, then tumbled by 33.96% to 85902000.0 in 2024, then rose by 2.14% to 87742000.0 in 2025.
  • Business Quant data shows Cash from Operations for TDOC at 87742000.0 in Q4 2025, 99264000.0 in Q3 2025, and 91432000.0 in Q2 2025.